ARIAD Pharma (ARIA) Tops Q4 EPS by 17c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 23.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.03 | 52 Week High | $14.34 | |||
| Open | $23.03 | 52 Week Low | $4.37 | |||
| Day High | $23.03 | P/E | N/A | |||
| Day Low | $23.03 | EPS | $-1.45 | |||
| Volume | 27 | |||||
